The Ensign Group, Inc. (ENSG)
USD 128.17
(-0.01%)
USD 128.17
(-0.01%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 353.23 Million USD | -1.98% |
| 2022 | 360.37 Million USD | 12.32% |
| 2021 | 320.83 Million USD | 13.96% |
| 2020 | 281.53 Million USD | 53.94% |
| 2019 | 182.88 Million USD | 3.77% |
| 2018 | 128.11 Million USD | 25.26% |
| 2017 | 100.13 Million USD | 16.84% |
| 2016 | 119.3 Million USD | -1.33% |
| 2015 | 122.03 Million USD | 22.1% |
| 2014 | 99.94 Million USD | -20.29% |
| 2013 | 90.85 Million USD | 4.7% |
| 2012 | 102.56 Million USD | 4.19% |
| 2011 | 111.68 Million USD | 24.22% |
| 2010 | 92.53 Million USD | 27.65% |
| 2009 | 72.49 Million USD | 22.53% |
| 2008 | 59.05 Million USD | 35.4% |
| 2007 | 43.69 Million USD | 1.35% |
| 2006 | 43.11 Million USD | 25.17% |
| 2005 | 34.44 Million USD | -85.91% |
| 2004 | 244.53 Million USD | 1742.08% |
| 2003 | 13.27 Million USD | 94.33% |
| 2002 | 6.83 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 106.62 Million USD | 53.35% |
| 2024 Q1 | 74.72 Million USD | 42.28% |
| 2024 Q3 | 122.17 Million USD | 6.61% |
| 2023 Q1 | 97.53 Million USD | 1.17% |
| 2023 Q3 | 102.51 Million USD | 1.83% |
| 2023 Q4 | 52.51 Million USD | -48.77% |
| 2023 Q2 | 100.67 Million USD | 3.22% |
| 2023 FY | - USD | -1.98% |
| 2022 Q1 | 82.97 Million USD | 0.59% |
| 2022 Q4 | 96.39 Million USD | 6.51% |
| 2022 FY | - USD | 12.32% |
| 2022 Q3 | 90.5 Million USD | 0.0% |
| 2022 Q2 | 90.5 Million USD | 9.08% |
| 2021 Q4 | 82.48 Million USD | 2.47% |
| 2021 FY | - USD | 13.96% |
| 2021 Q1 | 78.08 Million USD | 10.71% |
| 2021 Q2 | 79.77 Million USD | 2.16% |
| 2021 Q3 | 80.49 Million USD | 0.91% |
| 2020 FY | - USD | 53.94% |
| 2020 Q1 | 71.21 Million USD | 32.27% |
| 2020 Q4 | 70.53 Million USD | 1.23% |
| 2020 Q3 | 69.67 Million USD | -0.63% |
| 2020 Q2 | 70.12 Million USD | -1.53% |
| 2019 Q3 | 54 Million USD | 4.13% |
| 2019 Q4 | 53.83 Million USD | -0.3% |
| 2019 FY | - USD | 3.77% |
| 2019 Q1 | 50.97 Million USD | 7.93% |
| 2019 Q2 | 51.85 Million USD | 1.72% |
| 2018 FY | - USD | 25.26% |
| 2018 Q3 | 41.65 Million USD | -5.24% |
| 2018 Q2 | 43.95 Million USD | 1.32% |
| 2018 Q4 | 47.23 Million USD | 13.39% |
| 2018 Q1 | 43.38 Million USD | 13.78% |
| 2017 Q4 | 38.12 Million USD | 1.94% |
| 2017 FY | - USD | 16.84% |
| 2017 Q3 | 37.4 Million USD | 17.68% |
| 2017 Q1 | 33.37 Million USD | 14.74% |
| 2017 Q2 | 31.78 Million USD | -4.76% |
| 2016 Q2 | 29.85 Million USD | -8.92% |
| 2016 Q1 | 32.78 Million USD | 0.85% |
| 2016 Q3 | 28.68 Million USD | -3.94% |
| 2016 FY | - USD | -1.33% |
| 2016 Q4 | 29.08 Million USD | 1.41% |
| 2015 FY | - USD | 22.1% |
| 2015 Q3 | 29.11 Million USD | 1.96% |
| 2015 Q2 | 28.55 Million USD | -10.36% |
| 2015 Q1 | 31.85 Million USD | 28.01% |
| 2015 Q4 | 32.5 Million USD | 11.63% |
| 2014 Q4 | 24.88 Million USD | 23.72% |
| 2014 Q1 | 33.36 Million USD | -1.78% |
| 2014 Q2 | 21.58 Million USD | -35.33% |
| 2014 FY | - USD | -20.29% |
| 2014 Q3 | 20.11 Million USD | -6.79% |
| 2013 Q3 | 29.22 Million USD | -8.93% |
| 2013 Q2 | 32.09 Million USD | 6.61% |
| 2013 FY | - USD | 4.7% |
| 2013 Q4 | 33.97 Million USD | 16.23% |
| 2013 Q1 | 30.1 Million USD | 6.46% |
| 2012 FY | - USD | 4.19% |
| 2012 Q1 | 30.36 Million USD | 15.8% |
| 2012 Q2 | 30.25 Million USD | -0.36% |
| 2012 Q3 | 30.86 Million USD | 2.03% |
| 2012 Q4 | 28.27 Million USD | -8.4% |
| 2011 Q1 | 28.82 Million USD | 11.99% |
| 2011 Q2 | 29.73 Million USD | 3.17% |
| 2011 Q4 | 26.22 Million USD | -13.07% |
| 2011 FY | - USD | 24.22% |
| 2011 Q3 | 30.16 Million USD | 1.43% |
| 2010 Q1 | 21.7 Million USD | 7.77% |
| 2010 Q4 | 25.73 Million USD | 12.36% |
| 2010 FY | - USD | 27.65% |
| 2010 Q3 | 22.9 Million USD | 3.28% |
| 2010 Q2 | 22.18 Million USD | 2.17% |
| 2009 Q2 | 17.82 Million USD | 1.56% |
| 2009 Q1 | 17.54 Million USD | -1.97% |
| 2009 Q3 | 17.25 Million USD | -3.15% |
| 2009 Q4 | 20.14 Million USD | 16.72% |
| 2009 FY | - USD | 22.53% |
| 2008 Q1 | 13.26 Million USD | 4.66% |
| 2008 Q4 | 17.89 Million USD | 25.96% |
| 2008 Q3 | 14.21 Million USD | 3.03% |
| 2008 Q2 | 13.79 Million USD | 3.98% |
| 2008 FY | - USD | 35.4% |
| 2007 Q4 | 12.67 Million USD | 29.95% |
| 2007 Q3 | 9.75 Million USD | -18.99% |
| 2007 Q1 | 9.23 Million USD | 104.01% |
| 2007 FY | - USD | 1.35% |
| 2007 Q2 | 12.03 Million USD | 30.43% |
| 2006 Q1 | 89.64 Million USD | 146.29% |
| 2006 Q2 | 89.64 Million USD | 0.0% |
| 2006 Q3 | 89.64 Million USD | 0.0% |
| 2006 FY | - USD | 25.17% |
| 2006 Q4 | -230.03 Million USD | -356.61% |
| 2005 FY | - USD | -85.91% |
| 2005 Q3 | 75.21 Million USD | 0.0% |
| 2005 Q4 | -193.65 Million USD | -357.47% |
| 2005 Q2 | 75.21 Million USD | 0.0% |
| 2005 Q1 | 75.21 Million USD | 0.0% |
| 2004 FY | - USD | 1742.08% |
| 2003 FY | - USD | 94.33% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | -86.785% |
| Addus HomeCare Corporation | 106.55 Million USD | -231.496% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -1147.655% |
| Amedisys, Inc. | 216.91 Million USD | -62.847% |
| American Oncology Network, Inc. | -39.35 Million USD | 997.654% |
| Astrana Health, Inc. | 123.68 Million USD | -185.586% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -696.509% |
| IMAC Holdings, Inc. | -5.94 Million USD | 6039.939% |
| biote Corp. | 9.23 Million USD | -3725.384% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 3490.863% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | -173.117% |
| COMPASS Pathways plc | -123.8 Million USD | 385.323% |
| DocGo Inc. | 32.72 Million USD | -979.401% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -369.654% |
| InnovAge Holding Corp. | 1.15 Million USD | -30509.705% |
| Assure Holdings Corp. | -19.82 Million USD | 1881.86% |
| The Joint Corp. | 9.14 Million USD | -3763.999% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 436.652% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 2370.933% |
| ModivCare Inc. | -26.75 Million USD | 1420.508% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -91815.536% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 6139.254% |
| Option Care Health, Inc. | 376.79 Million USD | 6.252% |
| P3 Health Partners Inc. | -81.07 Million USD | 535.712% |
| P3 Health Partners Inc. | -81.07 Million USD | 535.712% |
| The Pennant Group, Inc. | 30.36 Million USD | -1063.147% |
| Surgery Partners, Inc. | 446.1 Million USD | 20.817% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 12555.931% |
| Talkspace, Inc. | -22.01 Million USD | 1704.67% |
| Talkspace, Inc. | -22.01 Million USD | 1704.67% |
| The Oncology Institute, Inc. | -70.45 Million USD | 601.371% |
| The Oncology Institute, Inc. | -70.45 Million USD | 601.371% |